Drug:
Reaction: MATERNAL EXPOSURE DURING PREGNANCY
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26908916 |
CN |
29 | 2 |
Ecchymosis, Maternal exposure during pregnancy, |
||||
FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, FONDAPARINUX SODIUM, |
||||
| 202 | 26909139 |
EG |
26 | 2 |
Caesarean section, Maternal exposure during pregnancy, Multiple sclerosis relapse, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 203 | 26909390 |
US |
36 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 204 | 26903870 |
US |
36 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 205 | 26904000 |
EU |
36 | 2 |
Transaminases increased, Maternal exposure during pregnancy, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 206 | 26904315 |
US |
37 | 2 |
Bacterial infection, Injection site pain, Product preparation issue, Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FOLIC ACID, |
||||
| 207 | 26902987 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
PALOPEGTERIPARATIDE, |
||||
| 208 | 26903046 |
US |
29 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 209 | 26903158 |
US |
28 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 210 | 26903228 |
US |
||
Maternal exposure during pregnancy, No adverse event, |
||||
RESMETIROM, |
||||
| 211 | 26903243 |
US |
||
Maternal exposure during pregnancy, No adverse event, |
||||
RESMETIROM, |
||||
| 212 | 26903251 |
US |
||
Maternal exposure during pregnancy, No adverse event, |
||||
RESMETIROM, |
||||
| 213 | 26903254 |
US |
||
Maternal exposure during pregnancy, No adverse event, |
||||
RESMETIROM, |
||||
| 214 | 26903400 |
US |
34 | 2 |
Cerebral haemorrhage, Loss of consciousness, Postpartum haemorrhage, Maternal exposure during pregnancy, Hemiplegia, Aphasia, Dysphagia, Anal incontinence, Urinary incontinence, |
||||
BUPIVACAINE, BUPIVACAINE HYDROCHLORIDE IN DEXTROSE, CEFAZOLIN SODIUM, CEFAZOLIN, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, PANTOPRAZOLE, MORPHINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYTOCIN, OXYTOCIN, |
||||
| 215 | 26903469 |
EU |
||
Hyperemesis gravidarum, Maternal exposure during pregnancy, |
||||
PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 216 | 26903475 |
EU |
||
Premature delivery, Maternal exposure during pregnancy, |
||||
PREGABALIN, MIRTAZAPINE, LORAZEPAM, |
||||
| 217 | 26903480 |
EU |
||
Premature delivery, Maternal exposure during pregnancy, |
||||
PREGABALIN, CELECOXIB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 218 | 26903481 |
EU |
||
Gestational diabetes, Maternal exposure during pregnancy, |
||||
PREGABALIN, AMOXICILLIN, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, RIZATRIPTAN, CYCLOBENZAPRINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 219 | 26903485 |
EU |
||
Premature delivery, Maternal exposure during pregnancy, |
||||
PREGABALIN, NAPROXEN, NAPROXEN SODIUM, |
||||
| 220 | 26903497 |
EU |
||
Gestational diabetes, Maternal exposure during pregnancy, |
||||
PREGABALIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RANITIDINE, |
||||
| 221 | 26903499 |
EU |
||
Premature delivery, Maternal exposure during pregnancy, |
||||
PREGABALIN, CICLOPIROX, |
||||
| 222 | 26897603 |
TN |
34 | 2 |
Foetal distress syndrome, Injection site pain, Maternal exposure during pregnancy, Normal newborn, |
||||
INTERFERON BETA-1A, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 223 | 26897612 |
CA |
32 | 2 |
Postpartum haemorrhage, Live birth, Maternal exposure during pregnancy, Nausea, Iron deficiency anaemia, Vomiting, |
||||
UPADACITINIB, UPADACITINIB, DULOXETINE HYDROCHLORIDE, DULOXETINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 224 | 26897696 |
CA |
37 | 2 |
Muscle spasms, Aphonia, Maternal exposure during pregnancy, Cough, Oropharyngeal pain, Malaise, Nail infection, Arthralgia, Caesarean section, Therapeutic response shortened, Maternal exposure before pregnancy, Hypotension, Maternal exposure during breast feeding, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, IRON, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, |
||||
| 225 | 26897719 |
GB |
2 | |
Pregnancy, Maternal exposure during pregnancy, |
||||
| 226 | 26897898 |
GB |
32 | 2 |
Fertility increased, Maternal exposure during pregnancy, |
||||
| 227 | 26897919 |
JP |
4 | 2 |
Arthritis, Normal newborn, Anaphylactic reaction, Swelling face, Arthralgia, Maternal exposure during pregnancy, |
||||
FERRIC DERISOMALTOSE, MAGNESIUM OXIDE, |
||||
| 228 | 26897993 |
CA |
17 | 2 |
Abortion spontaneous, Treatment noncompliance, Maternal exposure during pregnancy, |
||||
| 229 | 26898284 |
US |
29 | 2 |
Maternal exposure during pregnancy, |
||||
| 230 | 26898431 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 231 | 26898556 |
CA |
43 | 2 |
Irritable bowel syndrome, Muscle spasms, Glossodynia, Inflammation, Pain, Arthropathy, Nail disorder, Infusion related reaction, Impaired healing, Lung disorder, Lip dry, Hypertension, Musculoskeletal pain, Helicobacter infection, Hand deformity, Hypoaesthesia, Memory impairment, Hypercholesterolaemia, Joint swelling, Intentional product use issue, Muscle injury, Joint range of motion decreased, Infusion site reaction, Rheumatoid arthritis, Abdominal discomfort, Peripheral swelling, Pericarditis, Drug intolerance, Maternal exposure during pregnancy, Alopecia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CANDESARTAN, CANDESARTAN, HYDROMORPHONE HYDROCHLORIDE, LEFLUNOMIDE, CALCIUM GLUCONATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, AZATHIOPRINE, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, PANTOPRAZOLE, PANTOPRAZOLE, BUPRENORPHINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, BETAMETHASONE DIPROPIONATE, BETAMETHASONE DIPROPIONATE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, PHOSPHORUS, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, SARILUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CALCIUM CARBONATE, CERTOLIZUMAB PEGOL, TOFACITINIB, TOFACITINIB, TOFACITINIB, MINOCYCLINE HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, POVIDONE-IODINE, CALCIUM, CALCIUM, CALCIUM CARBONATE, ANTACID, BUPRENORPHINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, CORTISONE ACETATE, INFLIXIMAB, HYDROCORTISONE SODIUM SUCCINATE, PREDNISONE, FLUTICASONE PROPIONATE, ABATACEPT, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, ALENDRONATE SODIUM, ERGOCALCIFEROL, MELOXICAM, CAFFEINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 232 | 26898705 |
CA |
43 | |
Abdominal discomfort, Abdominal pain, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Condition aggravated, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Ear pain, Fatigue, Fibromyalgia, Gait disturbance, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Intentional product use issue, Joint range of motion decreased, Live birth, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Rash, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wheezing, Wound, Wound infection, Suspected off label use, Suspected off label use, Suspected off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, TOPIRAMATE, TOPIRAMATE, |
||||
| 233 | 26899010 |
US |
36 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 234 | 26899416 |
US |
53 | 2 |
Maternal exposure during pregnancy, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 235 | 26899685 |
US |
2 | |
Maternal exposure during pregnancy, Condition aggravated, |
||||
OMALIZUMAB, |
||||
| 236 | 26899694 |
US |
2 | |
Chest discomfort, Flushing, Dyspnoea, Maternal exposure during pregnancy, Infusion related reaction, |
||||
IRON DEXTRAN, |
||||
| 237 | 26899811 |
US |
30 | 2 |
Rheumatoid arthritis, Drug ineffective, Joint swelling, Maternal exposure during breast feeding, Maternal exposure during pregnancy, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 238 | 26899876 |
US |
2 | |
Maternal exposure before pregnancy, Maternal exposure during pregnancy, No adverse event, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 239 | 26899970 |
CA |
2 | |
Pulmonary fibrosis, Duodenal ulcer perforation, Abdominal discomfort, Alopecia, Arthropathy, Asthma, Autoimmune disorder, Blood cholesterol increased, Chest pain, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dyspepsia, Irritable bowel syndrome, Liver injury, Lower limb fracture, Maternal exposure during pregnancy, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Off label use, Pain, Pemphigus, Pericarditis, Pneumonia, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Exposure during pregnancy, Fatigue, Fibromyalgia, Folliculitis, Gait inability, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Impaired healing, Incorrect route of product administration, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wound, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, VITAMIN C, VITAMIN C, VITAMIN C, TOFACITINIB, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 240 | 26900027 |
US |
39 | |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
DOLUTEGRAVIR SODIUM, |
||||
| 241 | 26900290 |
US |
2 | |
Chest pain, Flushing, Dyspnoea, Palpitations, Maternal exposure during pregnancy, Oxygen saturation decreased, Ureteral disorder, |
||||
IRON DEXTRAN, |
||||
| 242 | 26900668 |
CA |
43 | 2 |
Breast cancer stage III, Duodenal ulcer perforation, Epilepsy, Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Bursitis, C-reactive protein increased, Confusional state, Depression, Diarrhoea, Dizziness, Dry mouth, Facet joint syndrome, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Migraine, Memory impairment, Lung disorder, Lower respiratory tract infection, Liver injury, Live birth, Lip dry, Joint swelling, Joint range of motion decreased, Irritable bowel syndrome, Intentional product use issue, Inflammation, Impaired healing, Hypoaesthesia, Hypertension, Hypercholesterolaemia, Drug intolerance, Maternal exposure during pregnancy, Drug ineffective, |
||||
APREMILAST, ETANERCEPT, ETANERCEPT, INFLIXIMAB, USTEKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB CITRATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, VITAMIN C, TOFACITINIB, TOFACITINIB, PREDNISONE, PREDNISONE, HYDROCORTISONE, HYDROXYCHLOROQUINE, CALCIUM CARBONATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, PREDNISONE, CYANOCOBALAMIN, LORAZEPAM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 243 | 26900725 |
JP |
2 | |
Condition aggravated, Foetal exposure during pregnancy, Maternal exposure during pregnancy, |
||||
SIROLIMUS, |
||||
| 244 | 26900907 |
EU |
0 | 1 |
Term birth, Maternal exposure during pregnancy, |
||||
PROPRANOLOL HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 245 | 26901738 |
CA |
40 | 2 |
Back injury, Maternal exposure during pregnancy, Fall, Arthralgia, Liver function test increased, Exposure during pregnancy, Muscle spasms, Bursitis, Dyspepsia, Nail disorder, Vomiting, Mobility decreased, Osteoarthritis, C-reactive protein increased, Confusional state, Blood cholesterol increased, Injury, Swelling, Drug hypersensitivity, Diarrhoea, Dyspnoea, Abdominal discomfort, Grip strength decreased, Hand deformity, Headache, Arthropathy, Abdominal distension, Maternal exposure timing unspecified, Malaise, Folliculitis, Onychomadesis, Memory impairment, Hypertension, Product label confusion, Gastrooesophageal reflux disease, Hypersensitivity, Normal newborn, Nausea, Onychomycosis, Peripheral swelling, Glossodynia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, CAFFEINE, CAFFEINE, CAFFEINE, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CANDESARTAN, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ADALIMUMAB, ADALIMUMAB, |
||||
| 246 | 26901835 |
27 | 2 | |
Maternal exposure during pregnancy, Infusion site extravasation, Infusion site discolouration, |
||||
| 247 | 26902149 |
US |
34 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 248 | 26902162 |
US |
37 | 2 |
Ruptured ectopic pregnancy, Maternal exposure before pregnancy, Maternal exposure during pregnancy, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 249 | 26902181 |
GB |
2 | |
Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, |
||||
| 250 | 26902232 |
US |
1 | |
Neonatal hypoxia, Maternal exposure during pregnancy, Maternal exposure before pregnancy, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 251 | 26902356 |
EU |
2 | |
Hypersensitivity, Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 252 | 26902464 |
EU |
39 | 2 |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
DIMETHYL FUMARATE, |
||||
| 253 | 26902594 |
US |
2 | |
Abortion induced, Uterine dilation and curettage, Post procedural infection, Maternal exposure during pregnancy, |
||||
RISANKIZUMAB-RZAA, |
||||
| 254 | 26902595 |
US |
35 | 2 |
Caesarean section, Live birth, Maternal exposure during pregnancy, Blood glucose increased, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, NALTREXONE, IRON, |
||||
| 255 | 26891899 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 256 | 26891922 |
US |
33 | 2 |
Premature labour, Maternal exposure during pregnancy, Dry skin, Shortened cervix, Skin exfoliation, Vaginal haemorrhage, Skin fissures, Live birth, Premature baby, |
||||
UPADACITINIB, UPADACITINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 257 | 26891981 |
US |
2 | |
Abscess intestinal, Maternal exposure during pregnancy, Fistula, Anorectal operation, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, PROMETHAZINE HYDROCHLORIDE, |
||||
| 258 | 26892118 |
AU |
||
Complication of pregnancy, Condition aggravated, Maternal exposure during pregnancy, |
||||
USTEKINUMAB-STBA, |
||||
| 259 | 26892140 |
CA |
44 | 2 |
White blood cell count increased, Drug tolerance, Dry mouth, Duodenal ulcer perforation, Hypoaesthesia, Dyspepsia, Ear pain, Epilepsy, Facet joint syndrome, Folliculitis, Gait inability, Helicobacter infection, Impaired healing, Infusion related reaction, Loss of personal independence in daily activities, Lower limb fracture, Maternal exposure during pregnancy, Muscle injury, Swelling, Swollen joint count, Swollen joint count increased, Urticaria, Wheezing, Inappropriate schedule of product administration, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, DEXAMETHASONE SODIUM PHOSPHATE, CANDESARTAN CILEXETIL, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, SARILUMAB, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TRAMADOL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 260 | 26892691 |
GB |
26 | 2 |
Reflux laryngitis, Maternal exposure during pregnancy, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, |
||||
| 261 | 26893586 |
US |
2 | |
Maternal exposure during pregnancy, Flushing, Product quality issue, Dyspnoea, Tachycardia, Infusion related reaction, |
||||
IRON DEXTRAN, IRON DEXTRAN, |
||||
| 262 | 26893680 |
US |
23 | 2 |
Maternal exposure during pregnancy, |
||||
AZACITIDINE, |
||||
| 263 | 26893928 |
US |
23 | 2 |
Maternal exposure before pregnancy, Maternal exposure during pregnancy, No adverse event, Off label use, |
||||
SATRALIZUMAB, RITUXIMAB, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, BACLOFEN, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, FAMOTIDINE, |
||||
| 264 | 26893980 |
US |
25 | 2 |
Maternal exposure before pregnancy, Pre-eclampsia, Influenza, Lyme disease, Joint effusion, Maternal exposure during pregnancy, |
||||
SATRALIZUMAB, BACLOFEN, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE, FAMOTIDINE, |
||||
| 265 | 26894212 |
US |
2 | |
Pruritus, Intentional product misuse, Off label use, Maternal exposure during pregnancy, |
||||
DUPILUMAB, DUPILUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CETIRIZINE HYDROCHLORIDE, |
||||
| 266 | 26894359 |
CA |
43 | 2 |
Breast cancer stage III, Night sweats, Dry mouth, Joint range of motion decreased, Blood cholesterol increased, Blister, Feeling hot, Red blood cell sedimentation rate increased, Osteoporosis, Dizziness, Inflammation, Abdominal pain upper, Headache, Maternal exposure during pregnancy, Asthenia, Peripheral swelling, Diarrhoea, Peripheral venous disease, Visual impairment, Abdominal discomfort, Taste disorder, Blepharospasm, Arthralgia, Migraine, General physical health deterioration, Pericarditis, Rash, Vomiting, Muscle spasms, Asthenia, Pain, Breast cancer stage II, Synovitis, Infusion related reaction, Dislocation of vertebra, Hepatic enzyme increased, Anti-cyclic citrullinated peptide antibody positive, C-reactive protein increased, Irritable bowel syndrome, Frequent bowel movements, Pyrexia, Joint swelling, Depression, Bursitis, Impaired healing, Lupus vulgaris, Product quality issue, Wound, Folliculitis, Exostosis, Lung disorder, Glossodynia, Psoriatic arthropathy, Exposure during pregnancy, Retinitis, Decreased appetite, Contraindicated product administered, Gastrooesophageal reflux disease, Weight increased, Memory impairment, Hypocholesterolaemia, Musculoskeletal pain, Live birth, Paraesthesia, Injury, |
||||
AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, MINOCYCLINE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, TRETINOIN, BUPRENORPHINE HYDROCHLORIDE, RAMIPRIL, PANTOPRAZOLE, CYCLOBENZAPRINE, TOPIRAMATE, TOPIRAMATE, APREMILAST, GOLIMUMAB, GOLIMUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, INFLIXIMAB, INFLIXIMAB, ABATACEPT, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MIRABEGRON, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, PREDNISONE, FLUTICASONE PROPIONATE, APREMILAST, TOFACITINIB, TOFACITINIB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, OXYCODONE, MEPOLIZUMAB, SECUKINUMAB, SECUKINUMAB, VITAMIN C, ERGOCALCIFEROL, NAPROXEN, NAPROXEN SODIUM, TOFACITINIB, TOFACITINIB CITRATE, BOTULINUM TOXIN TYPE A, ERGOCALCIFEROL, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ERENUMAB-AOOE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, BETAMETHASONE DIPROPIONATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRAMADOL HYDROCHLORIDE, MAGNESIUM CHLORIDE, CELECOXIB, CELECOXIB, MAGNESIUM HYDROXIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CANDESARTAN, CANDESARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PYRIDOXINE HYDROCHLORIDE, ADALIMUMAB-ADAZ, PHENYLEPHRINE HYDROCHLORIDE, FISH OIL, ALBUTEROL SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, QUETIAPINE FUMARATE, QUETIAPINE, LORAZEPAM, LISINOPRIL, RISEDRONATE SODIUM, |
||||
| 267 | 26894916 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 268 | 26895085 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
| 269 | 26895103 |
MX |
2 | |
Abortion induced, Maternal exposure during pregnancy, Multiple-drug resistance, Status epilepticus, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LACOSAMIDE, TOPIRAMATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, PROPOFOL, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, VASOPRESSIN, |
||||
| 270 | 26895609 |
31 | 2 | |
Maternal exposure during pregnancy, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 271 | 26895610 |
29 | 2 | |
Maternal exposure during pregnancy, Maternal exposure during delivery, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 272 | 26895613 |
23 | 2 | |
Maternal exposure during pregnancy, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 273 | 26895630 |
25 | 2 | |
Maternal exposure during pregnancy, Maternal exposure during delivery, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 274 | 26895633 |
32 | 2 | |
Maternal exposure during pregnancy, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PREDNISONE, |
||||
| 275 | 26895904 |
EU |
2 | |
Multiple organ dysfunction syndrome, Premature baby, Low birth weight baby, Maternal exposure during pregnancy, Maternal exposure before pregnancy, Neurological decompensation, Intraventricular haemorrhage, Cerebral haemorrhage, Neonatal respiratory distress syndrome, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LACOSAMIDE, VASOPRESSIN, PROPOFOL, CEFUROXIME, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FOLIC ACID, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, METRONIDAZOLE, METRONIDAZOLE TOPICAL, AMPHOTERICIN B, AMPHOTERICIN B, |
||||
| 276 | 26896660 |
GB |
41 | |
Abortion spontaneous, Maternal exposure during pregnancy, |
||||
| 277 | 26896674 |
37 | 2 | |
Oropharyngeal discomfort, Tachypnoea, Rash papular, Urticaria, Chest discomfort, Pruritus, Maternal exposure during pregnancy, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 278 | 26896796 |
30 | ||
Vomiting, Maternal exposure during pregnancy, Dehydration, Product use in unapproved indication, Nausea, Diarrhoea, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, C1 ESTERASE INHIBITOR RECOMBINANT, C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 279 | 26897249 |
EU |
4 | 1 |
Renal failure, Foetal growth restriction, Premature baby, Maternal exposure during pregnancy, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, HYDROXYCHLOROQUINE SULFATE, AMLODIPINE, PREDNISONE, |
||||
| 280 | 26897489 |
JP |
44 | 2 |
Type 1 diabetes mellitus, Constipation, Depression, Nausea, Maternal exposure during pregnancy, Normal newborn, |
||||
OFATUMUMAB, |
||||
| 281 | 26886688 |
US |
2 | |
Gestational hypertension, Maternal exposure during pregnancy, |
||||
RISANKIZUMAB-RZAA, PREDNISONE, METOCLOPRAMIDE HYDROCHLORIDE, MAGNESIUM, |
||||
| 282 | 26886864 |
US |
2 | |
Drug ineffective, Maternal exposure during pregnancy, |
||||
BUPRENORPHINE, |
||||
| 283 | 26886866 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
BUPRENORPHINE, |
||||
| 284 | 26886888 |
US |
||
Maternal exposure during pregnancy, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
| 285 | 26886980 |
GB |
28 | |
Maternal exposure during pregnancy, Stillbirth, |
||||
FOLIC ACID, |
||||
| 286 | 26887140 |
CA |
26 | 2 |
Drug ineffective, Maternal exposure during pregnancy, |
||||
| 287 | 26887147 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
BUPRENORPHINE, |
||||
| 288 | 26887274 |
CA |
22 | 2 |
Abortion spontaneous, Infection, Treatment noncompliance, Maternal exposure during pregnancy, |
||||
| 289 | 26887333 |
US |
39 | 2 |
Maternal exposure during pregnancy, |
||||
ENOXAPARIN SODIUM, |
||||
| 290 | 26887459 |
EU |
2 | |
Brain malformation, Congenital central nervous system anomaly, Cerebral ventricle dilatation, Foetal growth restriction, Oligohydramnios, Pre-eclampsia, Maternal exposure during pregnancy, |
||||
BENRALIZUMAB, BENRALIZUMAB, AMITRIPTYLINE HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, DIAZEPAM, |
||||
| 291 | 26887898 |
US |
2 | |
Maternal exposure during pregnancy, Product availability issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 292 | 26888203 |
US |
28 | 2 |
Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, |
||||
| 293 | 26888210 |
CN |
32 | 2 |
Ankylosing spondylitis, Maternal exposure during pregnancy, Off label use, Therapy interrupted, Product availability issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
| 294 | 26888294 |
CA |
40 | 2 |
Alopecia, Asthenia, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Depression, Dizziness, Drug hypersensitivity, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fall, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Lip dry, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle spasms, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Synovitis, Systemic lupus erythematosus, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, INFLIXIMAB, INFLIXIMAB, APREMILAST, SECUKINUMAB, ALENDRONATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 295 | 26888460 |
US |
32 | 2 |
Maternal exposure during pregnancy, |
||||
ADALIMUMAB-ADAZ, |
||||
| 296 | 26888682 |
US |
2 | |
Maternal exposure during pregnancy, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 297 | 26888695 |
MX |
26 | 2 |
Psychotic disorder, Maternal exposure during pregnancy, |
||||
LACOSAMIDE, PROPOFOL, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, TOPIRAMATE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, VASOPRESSIN, SEVOFLURANE, MEROPENEM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 298 | 26889323 |
US |
36 | 2 |
Maternal exposure during pregnancy, |
||||
DUPILUMAB, |
||||
| 299 | 26889445 |
27 | 2 | |
Retroplacental haematoma, Maternal exposure during pregnancy, |
||||
| 300 | 26889491 |
EU |
29 | 2 |
Maternal exposure during pregnancy, Vulval oedema, Oedema, Pre-eclampsia, |
||||
LABETALOL HYDROCHLORIDE, LABETALOL, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30